Is Palantir Stock a Millionaire Maker?
Palantir (NASDAQ:PLTR) has shot upward over the last year and…
Sell
40
NBIX Quote, Financials, Valuation and Earnings
Last price:
$109.71
Seasonality move
:
8.21%
Day range:
$105.45 - $109.55
52-week range:
$84.23 - $157.98
Dividend yield:
0%
P/E ratio:
32.40x
P/S ratio:
4.69x
P/B ratio:
4.10x
Volume:
1M
Avg. volume:
1.6M
1-year change:
-25.48%
Market cap:
$10.6B
Revenue:
$2.4B
EPS (TTM):
$3.29
Earnings Data
Next earnings date for NBIX
May 05
2025
Most recent earnings per share
$1.00
Missed by $0.93
(Feb 6/2025)
Consensus Estimate
$1.93
(Feb 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NBIX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $646.8M | -- | -- | $1.49 | -- |
| 05/05/2025 | Q1 | $561M | -- | -- | $1.09 | -- |
| 02/06/2025 | Q4 | $629.4M | $627.7M | $1.00 | $1.93 | -$0.93 |
| 10/30/2024 | Q3 | $602.8M | $622.1M | $1.24 | $1.82 | -$0.58 |
| 08/01/2024 | Q2 | $546.6M | $590.2M | $0.63 | $1.53 | -$0.90 |
| 05/01/2024 | Q1 | $512M | $515.3M | $0.42 | $1.29 | -$0.87 |
| 02/07/2024 | Q4 | $518.4M | $515.2M | $1.44 | $1.51 | -$0.07 |
| 10/31/2023 | Q3 | -- | -- | $0.82 | $1.33 | -$0.51 |
| 08/01/2023 | Q2 | -- | -- | $0.95 | $1.12 | -$0.17 |
| 05/03/2023 | Q1 | -- | -- | -$0.79 | $0.74 | -$1.53 |
| 02/06/2023 | Q4 | -- | -- | $0.88 | $1.44 | -$0.56 |
| 11/01/2022 | Q3 | -- | -- | $0.69 | $1.12 | -$0.43 |
| 08/04/2022 | Q2 | -- | -- | -$0.18 | $0.89 | -$1.07 |
| 05/04/2022 | Q1 | -- | -- | $0.14 | $0.59 | -$0.45 |
| 02/11/2022 | Q4 | -- | -- | -$0.08 | $0.88 | -$0.96 |
| 11/01/2021 | Q3 | -- | -- | $0.23 | $0.80 | -$0.57 |
| 08/03/2021 | Q2 | -- | -- | $0.43 | $0.76 | -$0.33 |
| 05/05/2021 | Q1 | -- | -- | $0.33 | $0.72 | -$0.39 |
| 02/04/2021 | Q4 | -- | -- | $3.58 | $0.90 | $2.68 |
| 11/09/2020 | Q3 | -- | -- | -$0.62 | $1.25 | -$1.87 |
| 08/03/2020 | Q2 | -- | -- | $0.81 | $1.02 | -$0.21 |
| 05/06/2020 | Q1 | -- | -- | $0.39 | $0.64 | -$0.25 |
| 02/04/2020 | Q4 | -- | -- | $0.35 | $0.75 | -$0.40 |
| 11/04/2019 | Q3 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 07/29/2019 | Q2 | -- | -- | $0.54 | $0.25 | $0.29 |
| 04/29/2019 | Q1 | -- | -- | -$1.12 | -$0.89 | -$0.23 |
| 02/05/2019 | Q4 | -- | -- | $0.19 | $0.19 | -$0.00 |
| 11/05/2018 | Q3 | -- | -- | $0.52 | $0.49 | $0.03 |
| 07/31/2018 | Q2 | -- | -- | -$0.07 | -$0.18 | $0.11 |
| 04/30/2018 | Q1 | -- | -- | -$0.47 | -$0.30 | -$0.17 |
| 02/13/2018 | Q4 | -- | -- | $0.07 | $0.16 | -$0.09 |
| 11/01/2017 | Q3 | -- | -- | -$0.13 | -$0.53 | $0.40 |
| 08/03/2017 | Q2 | -- | -- | -$0.68 | -$0.65 | -$0.03 |
| 05/09/2017 | Q1 | -- | -- | -$0.90 | -$0.72 | -$0.18 |
| 02/14/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/29/2015 | Q2 | -- | -- | -- | -- | -- |
Neurocrine Biosciences Earnings Questions
-
How Much did Neurocrine Biosciences Generate in Revenue Last Quarter?
Neurocrine Biosciences reported $627.7M worth of top line sales in its most recent quarter.
-
Did Neurocrine Biosciences Beat Earnings Last Quarter?
Neurocrine Biosciences announced earnings per share of $1.00 which represents a miss of analyst forecast a $1.93 per share.
-
Is Neurocrine Biosciences Profitable?
Neurocrine Biosciences reported $618.4M that represents $6.02 per share over the last quarter.
-
What is the Analyst Consensus for Neurocrine Biosciences EPS Next Year?
Neurocrine Biosciences's earnings are forecast to grow from $3.29 per share to $6.60 per share next year representing an increase of 96.41%.
-
When is Neurocrine Biosciences's Earnings Date?
Neurocrine Biosciences's next earnings date is May 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
62
RGC alert for May 2
Regencell Bioscience Holdings [RGC] is down 22.08% over the past day.
Buy
65
MYRG alert for May 2
MYR Group [MYRG] is up 5.11% over the past day.
Sell
35
FTAI alert for May 2
FTAI Aviation [FTAI] is up 3.53% over the past day.
